Ruth M. Rothstein CORE Center

Last updated

The Ruth M. Rothstein CORE Center is a medical facility in the Illinois Medical District, located at 2020 West Harrison Street in Chicago. It was founded by the Cook County Bureau of Health Services, and cares for people with diseases such as HIV/AIDS. In its mission statement, it explains its goals as:

Contents

to provide the highest quality care for persons and families affected by infectious diseases, with respect, dignity and compassion, without regard to the ability to pay; to ensure a patient-centered and consumer-guided environment; and to seek to better understand and to prevent these diseases through education and research.

Design and language access

The center was designed with the involvement of "clients and providers". Its design could be seen as futuristic, with glass and white walls throughout.

To address language access needs of diverse-linguistic populations, the center designated a Bilingual Clinic staffed with Spanish-speaking physicians and medical staff for Spanish-speaking consumers. An in-house Spanish language interpreter is staffed to assist patients with limited English proficiency at the facility. Interpreter services through telephonic and video remote interpreting are available for the deaf or hard of hearing and for less common spoken languages.

Education

As well as carrying out its duties to the community, the center provides medical tutoring about HIV/AIDS to local medics. The center has also made attempts to educate the community about the nature of such diseases, with education resources readily available at the site.

Care

The center focuses on social care, primary care and special care:

Social care

This involves subjects such as support groups and counselling programs. Legal assistance is also provided.

Primary care

Primary Care at the CORE Center involves screening for sexually transmitted diseases (STDs) and care units for HIV.

Special care

A wide range of special care is provided:

Research

Clinical studies

The CORE center performs some clinical studies into HIV/AIDS. These are first approved by the Research Committee and the Scientific Committee/Institutional Review Board. The studies are also observed by the Food and Drug Administration. Participants are then required to sign a consent form informing them of any possible danger. All studies are closely monitored by qualified nurses. Not everyone can participate: requirements have to be met so that the staff feel that it is safe to carry out the study.

Survey and observational

Surveys and observational studies are carried out to investigate the effects of diseases. As with the clinical studies, the participants must first meet requirements set by the center.

Notes

    41°52′28.2″N87°40′37.7″W / 41.874500°N 87.677139°W / 41.874500; -87.677139

    Related Research Articles

    The management of HIV/AIDS normally includes the use of multiple antiretroviral drugs as a strategy to control HIV infection. There are several classes of antiretroviral agents that act on different stages of the HIV life-cycle. The use of multiple drugs that act on different viral targets is known as highly active antiretroviral therapy (HAART). HAART decreases the patient's total burden of HIV, maintains function of the immune system, and prevents opportunistic infections that often lead to death. HAART also prevents the transmission of HIV between serodiscordant same-sex and opposite-sex partners so long as the HIV-positive partner maintains an undetectable viral load.

    The spread of HIV/AIDS has affected millions of people worldwide; AIDS is considered a pandemic. The World Health Organization (WHO) estimated that in 2016 there were 36.7 million people worldwide living with HIV/AIDS, with 1.8 million new HIV infections per year and 1 million deaths due to AIDS. Misconceptions about HIV and AIDS arise from several different sources, from simple ignorance and misunderstandings about scientific knowledge regarding HIV infections and the cause of AIDS to misinformation propagated by individuals and groups with ideological stances that deny a causative relationship between HIV infection and the development of AIDS. Below is a list and explanations of some common misconceptions and their rebuttals.

    <span class="mw-page-title-main">Cryptococcosis</span> Potentially fatal fungal disease

    Cryptococcosis is a potentially fatal fungal infection of mainly the lungs, presenting as a pneumonia, and brain, where it appears as a meningitis. Cough, difficulty breathing, chest pain and fever are seen when the lungs are infected. When the brain is infected, symptoms include headache, fever, neck pain, nausea and vomiting, light sensitivity and confusion or changes in behavior. It can also affect other parts of the body including skin, where it may appear as several fluid-filled nodules with dead tissue.

    The National Institute of Allergy and Infectious Diseases is one of the 27 institutes and centers that make up the National Institutes of Health (NIH), an agency of the United States Department of Health and Human Services (HHS). NIAID's mission is to conduct basic and applied research to better understand, treat, and prevent infectious, immunologic, and allergic diseases.

    AIDS-defining clinical conditions is the list of diseases published by the Centers for Disease Control and Prevention (CDC) that are associated with AIDS and used worldwide as a guideline for AIDS diagnosis. CDC exclusively uses the term AIDS-defining clinical conditions, but the other terms remain in common use.

    Clinical research is a branch of medical research that involves people and aims to determine the effectiveness (efficacy) and safety of medications, devices, diagnostic products, and treatment regimens intended for improving human health. These research procedures are designed for the prevention, treatment, diagnosis or understanding of disease symptoms.

    Armenicum is a drug invented in Armenia in 1998 that its developers claim is an effective treatment for HIV infection and a number of associated diseases. No rigorously monitored clinical trials of Armenicum have been published, and most HIV experts outside of Armenia do not endorse its use.

    The Women's Interagency HIV Study (WIHS) was established in August 1993 to investigate the impact and progression of HIV disease in women. The WIHS enrolls both HIV-positive and HIV-negative women. The core portion of the study includes a detailed and structured interview, physical and gynecologic examination, and laboratory testing. The WIHS participants are also asked to enroll in various sub-studies, such as cardiovascular, metabolic, musculoskeletal, and neurocognition. New proposals for WIHS sub-studies are submitted for approval by various scientific investigators from around the world.

    Merle Alden Sande was a leading American infectious-diseases expert whose early recognition of the looming public health crisis posed by AIDS led to the development of basic protocols for how to handle infected patients. He graduated from Washington State University and received his MD degree from the University of Washington, School of Medicine in Seattle.

    A glossary of terms used in clinical research.

    HIV Clinical Resource is a health information service in New York State, which provides clinical information and guidance on HIV for the use of healthcare providers and patients.

    Anita Rachlis, M.D. is a Canadian HIV/AIDS researcher and is the principal author of the HIV treatment guidelines in Canada. She is an associate scientist at the Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, in Toronto, Ontario, Canada.

    The Infectious Diseases Institute (IDI), established within Makerere University, is a Ugandan not-for-profit organization which aims to strengthen health systems in Africa, with a strong emphasis on infectious diseases; through research and capacity development. In pursuit of its mission both in Uganda and Sub-Saharan Africa, IDI provides care to People Living with HIV (PLHIV) and other infectious diseases, builds capacity among healthcare workers through training and ongoing support, maintains a focus on prevention, and carries out relevant research.

    HIV in pregnancy is the presence of an HIV/AIDS infection in a woman while she is pregnant. There is a risk of HIV transmission from mother to child in three primary situations: pregnancy, childbirth, and while breastfeeding. This topic is important because the risk of viral transmission can be significantly reduced with appropriate medical intervention, and without treatment HIV/AIDS can cause significant illness and death in both the mother and child. This is exemplified by data from The Centers for Disease Control (CDC): In the United States and Puerto Rico between the years of 2014–2017, where prenatal care is generally accessible, there were 10,257 infants in the United States and Puerto Rico who were exposed to a maternal HIV infection in utero who did not become infected and 244 exposed infants who did become infected.

    <span class="mw-page-title-main">Cultural competence in healthcare</span> Health care services that are sensitive and responsive to the needs of diverse cultures

    Cultural competence in healthcare refers to the ability for healthcare professionals to demonstrate cultural competence toward patients with diverse values, beliefs, and feelings. This process includes consideration of the individual social, cultural, and psychological needs of patients for effective cross-cultural communication with their health care providers. The goal of cultural competence in health care is to reduce health disparities and to provide optimal care to patients regardless of their race, gender, ethnic background, native languages spoken, and religious or cultural beliefs. Cultural competency training is important in health care fields where human interaction is common, including medicine, nursing, allied health, mental health, social work, pharmacy, oral health, and public health fields.

    <span class="mw-page-title-main">Voluntary Health Services hospital, Chennai</span> Hospital in Tamil Nadu, India

    Voluntary Health Services, popularly known as the VHS Hospital, is a multispecialty tertiary care referral hospital in the south Indian state of Tamil Nadu, reportedly serving the economically weaker sections of the society. It was founded in 1958 by Krishnaswami Srinivas Sanjivi, an Indian physician, social worker and a winner of Padma Shri and Padma Bhushan awards and is run by a charitable non governmental organization of the same name. The hospital is situated along Rajiv Gandhi Salai at Taramani, in Chennai.

    Project SIDA (1984–1991), or Projet SIDA, was a joint scientific project between Zaire, the United States, and Belgium to study AIDS in Central Africa. Headquartered in Kinshasa, Zaire (DRC), Projet SIDA was designed as a collaboration between foreign scientists with experience studying epidemics and local scientists and physicians familiar with the local culture and customs. Initiated in 1984, Project SIDA began under the direction of Jonathan Mann with funding from the U.S. and Belgium, as well as support from the Zairian government. Project SIDA was based at Mama Yemo hospital in Kinshasa.

    Roy D. Mugerwa was a Ugandan physician, cardiologist and researcher. His contribution to the world of academics include being a Professor Emeritus at Makerere University College of Health Sciences in Kampala, cardiology in Uganda, researching HIV/AIDS and tuberculosis, and his efforts to find an effective HIV vaccine.

    <span class="mw-page-title-main">Adaora Adimora</span> American doctor and academic (1956–2024)

    Adaora Alise Adimora was an American doctor and academic. She was the Sarah Graham Kenan Distinguished Professor of Medicine and professor of epidemiology at the University of North Carolina School of Medicine. Her research centered on the transmission of HIV, as well as other sexually transmitted infections (STIs), among minority populations. Her work highlighted the importance of social determinants of HIV transmission and the need for structural interventions to reduce risk. In 2019, she became an elected member of the National Academy of Medicine in recognition of her contributions.

    Susan Swindells is an AIDS researcher.